Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche's Ocrevus: A Rare First-Year Blockbuster

Feb 01 2018

• By Jessica Merrill

Related Content

Tecfidera Stands Out From The Pack Of 2013 Drug Launches

Jan 13 2014

Head Of The Class: A Star Stands Out Among 2014 Drug Launches

Jan 05 2015

All Systems Go as Roche MS Drug Ocrevus Secures EU Okay At Last

Jan 12 2018

A Year To Remember For US Drug Launches

Dec 29 2017

Roche Set For Disruptive Entry To MS Market With 'Brave' Ocrevus Pricing Strategy

Mar 29 2017

Related Companies

Roche Holding AG

Pfizer Inc.

Novartis AG

Bristol Myers Squibb Company

Biogen, Inc.

Johnson & Johnson

Bayer AG

Regeneron Pharmaceuticals, Inc.

GSK plc

Gilead Sciences, Inc.

Additional Topics

Launches Sales & Earnings Commercial BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.